Objective: Understanding the role of Multi-slice CT Urography(MSCTU) over Ultrasonography(US) in patients presenting with hematuria. Materials and Methods:Retrospective study enrolled 131 patients presenting with hematuria[microscopic hematuria(n=60)] and macroscopic hematuria(n=71)]who have undergone both MSCTU and US of urinary tract system simultaneously. Results of tests were compared with respective surgical and histopathological analysis of lesion. The cases obtained were bladder carcinoma, ureter carcinoma, renal carcinoma, urinary tract calculi and bladder inflammation. PASW-18^th statistical tool was used for obtaining statistical analysis and final interpretation of results. Results: The sensitivity and specificity of MSCTU and US for recognition of lesions presenting with macroscopic hematuria were 95.38%,83.33% and 81.54%,66.67% respectively and for those with microscopic hematuria were 96.08%,88.89% and 86.27%, 77.8 % respectively. The positive and negative likelihood ratios of MSCTU and US in macroscopic category were 5.73, 0.055 and 2.46, 0.277 respectively while for those in microscopic category were 8.65, 0.044 and 3.88, 0.176 respectively. In context to the sensitivity of MSCTU and US in patients presenting with macroscopic hematuriathedifferenceswere significant (McNemar's test,P=0.039)suggesting the tests are not similar whereas for those with microscopic hematuria the differences were not significant(McNemar's test, P=2.68) indicatingsimilarity between these tests.Conclusion:Diagnostic efficacy of MSCTU is found to be far superior over US for patients presenting with macroscopic hematuria, thus current practice of using it as a first line modality seems to be justified. However, for those presenting with microscopic hematuria MSCTU and ultrasonography shows near to similar resultsin accordance to MSCTU, thus US alone seems sufficient to exclude significant urinary tract lesions.

[1] LOOR,WHITTAKER J,RABRENIVICH V.National Practice recommendation for hematuria How to evaluate in the absence of strong evidence？[J].Perm J,2009,13(1):37-46.
[2] YAFI F A,APRIKIAN A G,TANGUAY S,et al.Patients with microscopic and gross hematuria:practice and referral patterns among primary care physicians in a universal health care system[J].Can Urol Assoc J,2011,5(2):97-101.
[3] PATEL J V,CHAMBERS C V,GOMELLA L G.Hematuria:etiology and evaluation for the primary care physician[J].Can J Urol,2008,15(1):54-61.
[4] SHARP V J,BARNES K T,ERICKSON B A.Assessment of asymptomatic microscopic hematuria in adults[J].Am Fam Physician,2013,88(11):747-54.
[5] RAZAVI S A,SADIGH G,KELLY A M,et al.Comparative effectiveness of imaging modalities for the diagnosis of upper and lower urinary tract malignancy: a critically appraised topic[J].Acad Radiol,2012,19(9):1134-1140.
[6] WASHBURN Z W,DILLMAN J R,COHAN R H,et al.Computed tomographic urography update: an evolving urinary tract imaging modality[J].Semin Ultrasound CT MR,2009,30(4):233-45.
[7] CAOILI E M,COHAN R H,KOROBKIN M,et al.Urinary tract abnormalities: initial experience with multi-detector row CT urography[J].Radiology,2002,222(2):353-360.
[8] CHA E K,TIRSAR L A,SCHWENTNER C,et al.Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer[J].World J Urol,2012,30(6):847-852.
[9] CAUBERG E C,NIO C Y,ROSETTE J M,et al.Computed tomography-urography for upper urinary tract imaging:is it required for all patients who present with hematuria？[J].J Endourol,2011,25(11):1733-1740.
[10] RODGERS M,NIXON J,HEMPEL S,et al.Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation[J].Health Technology Assessment,2006,10(18):1-276.
[11] ELIAS K,SVATEK R S,GUPTA S,et al.High risk patients with hematuria are not evaluated according to guideline recommendations[J].Cancer,2010,116(12):2954-2959.
[12] SUNG M K,SINGH S,KALRA M K.Current status of low dose multi-detector CT in the urinary tract[J].World J Radiol,2011,3(11):256-265.